These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1361823)

  • 1. Lovastatin in the treatment of hypercholesterolemia in CAPD.
    Krane NK; Stock G; Caballero M; Starks E
    Adv Perit Dial; 1992; 8():362-4. PubMed ID: 1361823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin in CAPD patients with hypercholesterolemia.
    De Vecchi A; Scalamogna A; Paparella M; Colombini M; Rovellini A; Pini C; Castelnovo C
    Adv Perit Dial; 1992; 8():331-3. PubMed ID: 1361817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering effects of lovastatin in CAPD patients.
    Jacobs RH; Lal SM; Nolph KD
    Adv Perit Dial; 1993; 9():288-90. PubMed ID: 8105945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patients.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Clin Ther; 1992; 14(1):68-76. PubMed ID: 1576628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
    Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
    Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin treatment of dyslipoproteinemia in patients on continuous ambulatory peritoneal dialysis.
    Li PK; Mak TW; Lam CW; Lai KN
    Perit Dial Int; 1993; 13 Suppl 2():S428-30. PubMed ID: 8399631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V.
    Biesenbach G; Zazgornik J
    Clin Nephrol; 1992 Jun; 37(6):274-9. PubMed ID: 1638777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
    Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of lovastatin in hypercholesterolemic women.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Clin Ther; 1992; 14(3):390-5. PubMed ID: 1638580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of lovastatin in primary hypercholesterolemia].
    Nakandakare ER; Garcia RC; Carré JM; Zerbinatti CV; Oliveira HC; Quintão EC
    Arq Bras Cardiol; 1989 May; 52(5):291-5. PubMed ID: 2690785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lovastatin. A new drug for the treatment of hypercholesterolemia].
    Abouganem D; Núñez P
    Rev Med Panama; 1990 Sep; 15(3):184-96. PubMed ID: 2284448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Mak TW; Chiu K; Mak GY; Leung CB; Lui SF; Lam CW; Lai KN
    Aust N Z J Med; 1993 Jun; 23(3):252-7. PubMed ID: 8352699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G
    Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.